Drugs Made In America Acquisition Corp. Units

Drugs Made In America Acquisition Corp. Units

DMAAU - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$228.89M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Drugs Made In America Acquisition Corp. UnitsDrugs Made In America Acquisition Corp. Units55.6-4%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$228.89 Million
Enterprise Value$229.82 Million
Earnings per Share$0.19
Beta0.18
Outstanding Shares20,095,314

Return

Return on Equity4.42%ROE
Return on Assets4.15%
Return on Invested Capital-1.83%

Valuation & Multiples

P/E Ratio55.55P/E Ratio
PEG-226.35PEG
Price to Sales-Price to Sales
Price to Book Ratio1.9Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-87.27
Enterprise Value to Net Income37
Total Debt to Enterprise0
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.01%▼ 0.05%
Total Invested$16,548▼ 86.47%
Investors Holding1▼ 1.00%

About Drugs Made In America Acquisition Corp. Ordinary Shares

2 employees
CEO: Roger Bendelac

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with...